Food and Drug Administration

Nestle S.A. (OTC: NSRGY) subsidiary Nestle Health Sciences (NHSc) is aquiring biopharma company Aimmune Therapeutics, Inc. (Nasdaq: AIMT), under a definitive agreement, the latter announced Monday, sending its stock soaring in the pre-market session. What Happened: NHSc will purchase...

The United States Food and Drug Administration granted emergency use authorization to a 15-minute COVID-19 test produced by Abbott Laboratories (NYSE: ABT) on Wednesday. What Happened:The BinaxNOW COVID-19 test, priced at $5, is capable of delivering test results without laboratory...

Health and Human Services Secretary Alex Azar and the Food and Drug Administration announced Wednesday that the Trump administration has dropped a long-standing resistance to importing drugs and outlined a plan that could eventually allow the importation of some cheaper prescription drugs from...

In what could potentially be a breakthrough for the U.S. CBD market, the Food and Drug Administration announced the first public hearing to obtain more data about CBD products. The announcement comes as the FDA and FTC is sending warning letters to three companies that sell CBD products, accusing...

Shares of GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) were halted Thursday, ahead of a Food and Drug Administration vote on the company's cannabis-derived drug Epidiolex. Trading resumed after the FDA advisory panel voted unanimously in favor of approving the medicine for the treatment of two...

Puma Biotechnology Inc (NASDAQ: PBYI) popped 88 percent Monday on news that its neratinib candidate, an early-stage breast cancer treatment for human epidermal growth factor receptor-2 (HER2) positive mutations, was advancing in the U.S. Food and Drug Administration investigatory process. For...

The U.S. Food and Drug Administration sent warning letters Tuesday to LifeVantage Corp (NASDAQ: LFVN) and 13 other companies engaged in the illegal sale of more than 65 products purported but unproven to prevent, diagnose or treat cancer. The regulatory agency listed LifeVantage’s Protandim...

In response to a Wednesday letter by the U.S. Food and Drug Administration, which highlighted numerous regulatory violations on the part of Abbott Laboratories (NYSE: ABT), Abbott told Benzinga that “patient safety comes first” and the firm prioritizes compliance with regulatory...

From healthcare to finance to natural resources, everyone is reeling from federal administration shakeups and their various market implications. But Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) CEO Mark Baker is unconcerned by leadership and regulatory changes at the U.S. Food and Drug...

Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) were trading higher by 20 percent at one point early Friday morning on no confirmed news reports. Sarepta's investor relations website showed no new updates. Meanwhile, Twitter users were sharing various theories to explain the unexpected surge in...

On Tuesday, a U.S. regulatory panel voted in favor of the Food and Drug Administration approving a knockoff arthritis drug that would rival Johnson & Johnson (NYSE: JNJ)'s Remicade. A blow to Johnson & Johnson, the decision was good news for Pfizer Inc. (NYSE: PFE), which holds the license...